Diminished loss of proteoglycans and lack of albuminuria in protein kinase C-alpha-deficient diabetic mice - Wikidata - awgldk - TriplyDB

Diminished loss of proteoglycans and lack of albuminuria in protein kinase C-alpha-deficient diabetic mice

Diminished loss of proteoglycans and lack of albuminuria in protein kinase C-alpha-deficient diabetic mice

http://www.wikidata.org/entity/Q28274074

about

Alterations of renal phenotype and gene expression profiles due to protein overload in NOD-related mouse strains Diabetic Kidney Disease: Pathophysiology and Therapeutic Targets mTOR signaling in tumorigenesis PKC-beta1 mediates glucose-induced Akt activation and TGF-beta1 upregulation in mesangial cells.Podocytic PKC-alpha is regulated in murine and human diabetes and mediates nephrin endocytosis.Hyperglycemia induces oxidative stress and impairs axonal transport rates in mice.Activation of protein kinase C isoforms and its impact on diabetic complications.Glycoxidised LDL induced the upregulation of Axl receptor tyrosine kinase and its ligand in mouse mesangial cells.Sulodexide decreases albuminuria and regulates matrix protein accumulation in C57BL/6 mice with streptozotocin-induced type I diabetic nephropathy Crucial roles of the protein kinases MK2 and MK3 in a mouse model of glomerulonephritis.New insight into the molecular drug target of diabetic nephropathy.Different localization and expression of protein kinase C-beta in kidney cortex of diabetic nephropathy mice and its role in telmisartan treatment.Novel Therapies for Diabetic Kidney Disease: Storied Past and Forward Paths.Role of VEGF in maintaining renal structure and function under normotensive and hypertensive conditions Glomerular VEGF resistance induced by PKCδ/SHP-1 activation and contribution to diabetic nephropathy.Agents in development for the treatment of diabetic nephropathy.Influence of protein kinase C (PKC) on the prognosis of diabetic nephropathy patients.Vascular complications of diabetes: mechanisms of injury and protective factors Tandem inhibition of PKC in Diαβetic nephropathy: it takes two to tango?Regulation of transforming growth factor beta in diabetic nephropathy: implications for treatment.Protein kinase C beta inhibitors: a new therapeutic target for diabetic nephropathy and vascular complications.What are new avenues for renal protection, in addition to RAAS inhibition?Childhood nephrotic syndrome--current and future therapies.The renal endothelium in diabetic nephropathy.Pathophysiology of the diabetic kidney.Molecular and cellular events mediating glomerular podocyte dysfunction and depletion in diabetes mellitus.Role of protein kinase C in podocytes and development of glomerular damage in diabetic nephropathy.Podocyte directed therapy of nephrotic syndrome-can we bring the inside out?Caveolin-1 in the Pathogenesis of Diabetic Nephropathy: Potential Therapeutic Target?Dual inhibition of classical protein kinase C-α and protein kinase C-β isoforms protects against experimental murine diabetic nephropathy.PKCdelta regulates the stimulation of vascular endothelial factor mRNA translation by angiotensin II through hnRNP K.Antioxidants ameliorate the expression of vascular endothelial growth factor mediated by protein kinase C in diabetic podocytes.Diabetic Microvascular Disease: An Endocrine Society Scientific Statement.Effect of total glucosides of paeony on the expression of nephrin in the kidneys from diabetic rats.Amelioration of diabetic nephropathy by oral administration of d-α-tocopherol and its mechanisms.Caveolin-1 deficiency protects against mesangial matrix expansion in a mouse model of type 1 diabetic nephropathy.

P2860

Q25257361-52400CD0-3DB4-4545-826D-1AE9415C8ECB Q28086840-1389489A-EA58-4DF6-A868-D3A8D1AED132 Q28252695-728CC189-D984-4DA1-9240-A283950AE85F Q30436921-F891F09F-72CC-4FBF-91AA-3AF7D4E7A9D9 Q33564333-3AB1A9A0-C0B4-43E6-B319-B98F1C563242 Q33728395-627947FE-D838-4A57-8588-9A2E14C3C145 Q33881442-F4693AFC-EFBE-4727-BD67-68C390B7F818 Q34505237-77CA5DEA-4D6F-4E1B-950F-E2FEDBB59A3F Q34563204-A3EB9481-429D-4BC9-B599-5F7AD54E2CA5 Q34571047-6728818C-BAB5-426F-A771-6E6F1D6CEAF7 Q35125585-B2323096-B5E1-4887-828B-8EBA05F5F734 Q35747591-5239354E-EF9E-48F8-8178-171B18BE72D9 Q35953867-7175C341-C20C-4D52-9259-5D661B95FD0F Q35971694-1BD5D9A2-0F51-4736-817E-9848F14B5FC6 Q36055520-20B20BE9-7994-4496-92B2-11548C0DC825 Q36099419-32E62FFD-BD1B-48E1-A779-261865218399 Q36464709-15C79DA5-DFEF-4BBF-9D92-2434C5DC0913 Q36537262-84FC1AE2-B6EE-4E4E-878B-66FEEAFCF99D Q36720570-EE80BDC3-F4B3-4574-8D91-E1164298F30C Q36785571-A6A47B26-89AC-45F2-834A-69062F41A94A Q37165694-D9C95251-B282-4B99-AFB4-66B1F355F75B Q37980677-215C21A7-60C1-4761-9752-C0CC9E01C832 Q38017937-781C50B6-7644-41A7-83C1-B2CAB76BA78A Q38087656-3E67F476-3B9B-4F9D-80C1-8D799D45BE4F Q38111707-75E9F691-77BC-4BB0-8C22-FDDDC7AB4369 Q38259562-CD92964C-0321-4879-AB7E-3B6AF4E9B8E6 Q38270180-64FC33A2-4B98-4888-945B-A82134E559EA Q38458152-94D09A4F-DEA9-4FB3-AF80-3830AF927EF0 Q39173742-760F34FE-075C-40FC-A7C3-B8316FC965C5 Q39349244-8F71B1DA-5447-4BF1-8261-EC552F2F65A2 Q40009675-469756EC-F6AE-43E0-9303-EB9B509A3584 Q40315191-28ECDE81-089B-4A80-9569-8F31BEEB6680 Q45072634-D836A115-69F3-4B50-9F3C-6FEA083916E5 Q45977204-15C07C44-91CB-42D8-8E81-C9FE874E9DBB Q47235747-106F0298-240E-453B-A268-9F49B947A0AB Q50884558-045CCED9-89CF-465E-9374-7D362E29F175

P2860

Diminished loss of proteoglycans and lack of albuminuria in protein kinase C-alpha-deficient diabetic mice

http://www.wikidata.org/entity/Q28274074

description

2004 nî lūn-bûn

@nan

2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Diminished loss of proteoglyca ...... -alpha-deficient diabetic mice

@ast

Diminished loss of proteoglyca ...... -alpha-deficient diabetic mice

@en

Diminished loss of proteoglyca ...... -alpha-deficient diabetic mice

@nl

type

label

Diminished loss of proteoglyca ...... -alpha-deficient diabetic mice

@ast

Diminished loss of proteoglyca ...... -alpha-deficient diabetic mice

@en

Diminished loss of proteoglyca ...... -alpha-deficient diabetic mice

@nl

prefLabel

Diminished loss of proteoglyca ...... -alpha-deficient diabetic mice

@ast

Diminished loss of proteoglyca ...... -alpha-deficient diabetic mice

@en

Diminished loss of proteoglyca ...... -alpha-deficient diabetic mice

@nl

P1433

Q28274074-577FBDB8-2803-4AD9-B56E-13337E2D42A2

P1476

Q28274074-D6A15B2F-1901-4A51-A267-DDE82B8BF274

P2093

Q28274074-0C75FBA0-54F1-43C5-B324-7AFFE80C4E32

Q28274074-1EEF80F7-8093-4F07-8BF9-BB8817ADEC05

Q28274074-2C2F7EBB-50B3-4EFE-A2C2-6E33819088B0

Q28274074-58A40739-8321-4553-9A75-015B2CA8AFA7

Q28274074-60DFE5E9-138A-417F-934C-5D9D28818C2A

Q28274074-6E5E6AB6-DED1-49D0-91E2-8E35567FD393

Q28274074-85625EA7-802F-41F2-9E58-204A456B63E8

Q28274074-C2E3A23F-17BC-4F37-99BA-76F0F3156150

Q28274074-D04AACA0-9002-4765-9334-54AABB33B5E2

Q28274074-DEE67D3D-10FB-4203-AD0E-540FBE1334D5

P304

Q28274074-122021B7-9E44-4BDA-95EE-9C758DAE0697

P31

Q28274074-D10642E7-B372-4C21-89C3-A925FE0A8FF6

P356

Q28274074-E8941AC1-7A80-4108-A077-C26B9EA601FC

P407

Q28274074-22F7C333-53C4-4931-AD90-D1978C595355

P433

Q28274074-584DC6B5-A4F4-4421-A7F3-EF75475EB039

P478

Q28274074-59035ADA-9043-4553-A1E7-733E142DCBF8

P50

Q28274074-77038792-654F-4B41-8B73-4EB05A14FE48

P577

Q28274074-240B7BFE-3BB6-4767-B243-7225D98FD46A

P5875

Q28274074-40915CFD-ED57-4EA4-AAEE-867338CDEC84

P698

Q28274074-95BBE254-9991-4750-AD69-C27975895871

P356

DIABETES.53.8.2101

P1433

P1476

Diminished loss of proteoglyca ...... -alpha-deficient diabetic mice

@en

P2093

Annette Fiebeler

http://www.w3.org/2001/XMLSchema#string

Carsten Lindschau

http://www.w3.org/2001/XMLSchema#string

Faikah Gueler

http://www.w3.org/2001/XMLSchema#string

Ferdinand H Bahlmann

http://www.w3.org/2001/XMLSchema#string

Jan Menne

http://www.w3.org/2001/XMLSchema#string

Joon-Keun Park

http://www.w3.org/2001/XMLSchema#string

Marlies Elger

http://www.w3.org/2001/XMLSchema#string

Martin Boehne

http://www.w3.org/2001/XMLSchema#string

Matthias Meier

http://www.w3.org/2001/XMLSchema#string

Michael Leitges

http://www.w3.org/2001/XMLSchema#string

P304

2101-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DIABETES.53.8.2101

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

53

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8433163

http://www.w3.org/2001/XMLSchema#string

P698

15277392

http://www.w3.org/2001/XMLSchema#string